Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.27 billion. The enterprise value is $1.32 billion.

Market Cap	1.27B
Enterprise Value	1.32B

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 132.69 million shares outstanding. The number of shares has increased by 19.62% in one year.

Current Share Class	132.69M
Shares Outstanding	132.69M
Shares Change (YoY)	+19.62%
Shares Change (QoQ)	+3.36%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	65.39%
Float	116.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	116.24
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86

Current Ratio	2.86
Quick Ratio	2.30
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -522.08% and return on invested capital (ROIC) is -152.19%.

Return on Equity (ROE)	-522.08%
Return on Assets (ROA)	-106.25%
Return on Invested Capital (ROIC)	-152.19%
Return on Capital Employed (ROCE)	-263.99%
Revenue Per Employee	n/a
Profits Per Employee	-$3.05M
Employee Count	256
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biohaven has paid $1.14 million in taxes.

Income Tax	1.14M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.27% in the last 52 weeks. The beta is 3.59, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.59
52-Week Price Change	-79.27%
50-Day Moving Average	13.00
200-Day Moving Average	17.37
Relative Strength Index (RSI)	42.32
Average Volume (20 Days)	4,613,042

Short Selling Information

The latest short interest is 13.13 million, so 9.89% of the outstanding shares have been sold short.

Short Interest	13.13M
Short Previous Month	10.30M
Short % of Shares Out	9.89%
Short % of Float	11.27%
Short Ratio (days to cover)	2.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-781.68M
Pretax Income	-778.97M
Net Income	-780.11M
EBITDA	-771.87M
EBIT	-781.68M
Earnings Per Share (EPS)	-$7.59

Full Income Statement

Balance Sheet

The company has $260.22 million in cash and $314.18 million in debt, giving a net cash position of -$53.96 million or -$0.41 per share.

Cash & Cash Equivalents	260.22M
Total Debt	314.18M
Net Cash	-53.96M
Net Cash Per Share	-$0.41
Equity (Book Value)	-17.16M
Book Value Per Share	-0.16
Working Capital	210.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$649.52 million and capital expenditures -$756,000, giving a free cash flow of -$650.27 million.

Operating Cash Flow	-649.52M
Capital Expenditures	-756,000
Free Cash Flow	-650.27M
FCF Per Share	-$4.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.62%
Shareholder Yield	-19.62%
Earnings Yield	-61.56%
FCF Yield	-51.32%

Dividend Details

Analyst Forecast

The average price target for Biohaven is $29.79, which is 211.94% higher than the current price. The consensus rating is "Buy".

Price Target	$29.79
Price Target Difference	211.94%
Analyst Consensus	Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1